REG - Clean Power Hydrogen - Manufacturing Partnership with Kenera

Clean Power HydrogenAnnouncement

27/06/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250627:nRSa6543Oa&default-theme=true

RNS Number : 6543O  Clean Power Hydrogen  27 June 2025

27 June 2025

 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

 

CPH2 Activates Licenced Manufacturing Partnership with Kenera

 

 

CPH2, the UK-based green hydrogen technology and manufacturing company that
has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased
to announce the submission of its manufacturing and design licence
documentation ("licence package") to its licensee Kenera, a Helmerich &
Payne ("H&P") Company.

 

The licence pack will allow Kenera to review the final MFE design packages and
system assemblies in order for the teams to begin the process of building the
first MFE electrolysers under its agreement. The full document pack includes:
Process, Mechanical, Electrical and Safety Design Package; Bill of materials
with every part defined; 3D layout defined for the electrolyser and all
sub-assemblies.

 

CPH2 has granted Kenera a non-exclusive licence to sell and manufacture CPH2
products in Germany, Scotland, Azerbaijan, Denmark and Norway as well as an
exclusive licence to sell and manufacture CPH2 products across the Middle East
up to a maximum level of 2GW (including Oman, Saudi Arabia, United Arab
Emirates, Qatar, Kuwait and Iraq).

 

Kenera can now begin the process of planning to commence production. The
Kenera and CPH2 teams will continue to work closely together focused on the
transfer of MFE design, assembly and testing requirements, as well as
completing, staff training, supplier onboarding and production line readiness.

 

 

Jon Duffy, CEO of Clean Power Hydrogen commented:

"Activating our licence with Kenera through the submission of this licence
package is a significant achievement and maintains the flow of progress in the
deployment of our licence model, which aims to quickly scale the utilisation
of our MFE technology. We look forward to working with Kenera to advance its
build and have another MFE unit operational in the field."

 

 

Rebecca Clarke, SVP Kenera commented:

"We are delighted to have received the licence pack. We are keen to begin
production as soon as it is feasibility possible and will work with CPH2 to
expedite this."

 

 

 

 

ENDS

 

 

For more information, please contact:

 

 Clean Power Hydrogen plc                                via Camarco
 Jon Duffy, Chief Executive Officer

 James Hobson, Chief Financial Officer

 Cavendish Capital Markets Limited - NOMAD & Broker
 Neil McDonald                                           +44 (0)131 220 9771
 Peter Lynch                                             +44 (0)131 220 9772
 Adam Rae                                                +44 (0)131 220 9778

 Camarco PR                                              + 44(0) 20 3 757 4980
 Owen Roberts
 Kirsty Duff

 

To find out more, please visit: https://www.cph2.com (https://www.cph2.com)

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has
almost a decade of dedicated research and product development experience. This
experience has resulted in the creation of simple, safe and sustainable
technology which is designed to deliver a modular solution to the hydrogen
production market in a cost-effective, scalable, reliable and long-lasting
manner. The Group's strategic objective is to deliver the lowest LCOH in the
market in relation to the production of green hydrogen. CPH2 is listed on the
AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCDZGZVGVZGKZZ